Sign in
4

Changes in Ownership

Greenwich LifeSciences, Inc. Filed Acc 0001493152-23-034479

VP Clinical Reg Affairs bought 600 shares at $8.71 ($5,226)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Thompson Jaye VP Clinical Reg Affairs 2023-09-26 Purchase +600 $8.71 $5,226 259,848 D
Open-market purchases · 600 sh · avg $8.71 · $5,226
Loading xslF345X05/ownership.xml…